Simultaneous administration of trichloroethylene (TCE), at an oral dose of 0.5 mVkg, resulted in a marked potentiation of liver injury caused by an oral dose of carbon tetrachloride (CCl,, 0.05 mVkg). Hepatic glutathione levels were depressed at 24 hr only in the rats given TCE and CCl,. Using serum enzyme (ALT and SDH) as indicators of hepatotoxicity, potentiation of CCl,-injury was most apparent at 24 hr. Upon histological examination of H&E stained liver sections, the differences between livers obtained from TCE and CC1,-treated rats versus CC1,-treated rats were most apparent at later time points (48 and 72 hr). At 48 hr after CCl,, livers showed a distinctive and uniform pattern of injury with regeneration features predominating over necrosis. At this time, livers from TCE and CC1,-treated rats were characterized by extensive zone 3 coagulative necrosis. Inflammatory infiltrations were less prominent. At 72 hr, morphological features of livers from TCE and CCl, rats were similar to those from ralSgven CCl, alone at 48 hr. From the results obtained, it appears that the regenerative activity of the liver may be delayed in rats simultaneously administered TCE and CCI, as compared to rats administered only CCI,.
INTRODUCTION
The traditional goal of a toxicology study is to thoroughly characterize the effects of a particular chemical@) of interest. To ensure that only the effect(s) of the chosen chemical($ are observed, the purest available form is normally studied under carefully controlled conditions in some animal model or in viiro system. Human exposures, however, rarely, if ever, involve a single chemical agent under precisely known conditions. Consequently, interactions among chemicals and other environmental factors may lead to unexpected toxicity. Defining the characteristics and mechanism(s) of such interactions is critical to ultimately predicting and minimizing their potential impact on human health.
Studies in our laboratory have focused on the combined effects of 2 chlorinated compounds, namely, carbon tetrachloride (CCI,) and trichloroethylene (TCE). The toxicities of these agents and how they interact are of considerable practical concern since both are frequently identified as ground water and/ or drinking water contaminants (4, 13) and consequently may pose a health risk to large populations. Various investigators (3, 5, 14) have reported that coadministration of CCI, and TCE produces a greater-than-additive injury to the liver in rats. This interaction has been variously defined as a synergism, since both comljounds are known hepatotoxicants, or as a potentiation of CCl, toxicity, since the interaction occurs following doses of TCE that, by themselves, do not produce detectable hepatotoxicity (16) . Our own studies (22) have shown that the TOXICOLOGIC PATHOLOGY uated (9, 14, 20) , no conclusive answer has emerged. One limitation of previous studies, including our own, is that histologic evaluation of hepatic injury produced by this combination of compounds has been carried out only at a single time point following dosing. While indirect markers of hepatotoxicity [e.g., plasma enzyme activities (1 5)] have been shown to reflect the observed histopathology 24 hr after dosing, no comparison is available covering the entire time course of injury. Consequently, it has not been documented how soon the synergistic injury can be observed in the target tissue itself or how the histopathology changes with time. In fact, a recent study ofCC1, hepatotoxicity in F-344 rats has shown that given levels of marker enzymes in plasma may correspond to markedly different levels of histologic injury, depending on the duration of dosing and the period ofrecovery since the initial injury (2). Similar arguments apply to evaluation of the hepatic concentration of reduced glutathione (GSH) over the course of injury and recovery. Pessayer et a1 (14) reported that GSH was slightly depleted at 2.5 and 24 hr after dosing with CCl, and TCE, although not after CCl, alone. While they argued that the observed depletion (approximately 20%) is too small to be mechanistically significant, it is not known whether this represents the minimum value attained, how long the depletion persists, or whether a greater depletion may occur in the more sensitive F-344 strain. The goal of this study was to use the F-344 rat model of synergistic hepatotoxicity to create a time profile of histological changes. The postdosing intervals were selected to facilitate analysis of all phases of the injury from earliest onset through repair and recovery. In addition, indirect indicators of hepatotoxicity were examined at the same times to determine how well they correlated with the histologic evidence.
MATERIALS AND METHODS
Animals and Chemicals. Male F-344 rats (1 50-200 g) were purchased from Harlan Sprague-Dawley (Indianapolis, IN). Rats were housed in an approved animal care facility with a 12-hr light-dark cycle and allowed free access to food (Wayne Lab-Blox) and water except as otherwise noted. The animals were acclimated for at least 7 days prior to the study. All experimental protocols were reviewed and approved by the appropriate Institutional Animal Use Committee. CCl,, high-performance liquid chromatography grade, and TCE, spectrophotometric grade, were purchased from Aldrich Chemical Co. (Milwaukee, WI). Purity was confirmed by gas-chromatographic analysis as previously described (22) . Emulphor 620P (a polyoxyethylated castor oil) was obtained from the GAF Corporation (Linden, NJ). Glutathione S-transferase, reduced glutathione, and 1 -chloro-2,4-dinitrobenzene were purchased from the Sigma Chemical Co. (St. Louis, MO). All other chemicals used were ofthe highest available grade.
Treatment of AnimaWDose Selection. Dosing solutions were prepared immediately prior to use by dissolving the test chemical(s) in Emulphor and adding glass-distilled water to form a 10% emulsion. When both CCl, and TCE were administered, they were combined in a single dosing solution. All doses were administered by oral gavage at a volume of 2.5 mVkg body weight. To minimize variability in oral absorption, rats were fasted overnight (16 hr) prior to dosing between 7:OO and 9:00 the next morning. The following treatments were evaluated: 10% Emulphor (vehicle control), TCE (0.5 mVkg), CCl, (0.05 mVkg), or TCE + CCl,. Doses were based on previous experiments (22) which showed that for F-344 rats 0.05 mVkg of CCl, produced a minimal hepatotoxic response that was significantly potentiated by 0.5 mVkg TCE. This dose of TCE did not, by itself, produce any detectable hepatotoxicity. Each treatment was administered to a group of 24 rats (a total of 96 animals). At intervals of 3,6, 12,24,48, and 72 hr after dosing, 4 rats randomly chosen from each group were killed by CO, asphyxiation. Blood was collected in heparinized tubes and used to prepare plasma for evaluation of the hepatotoxic response. Plasma alanine aminotransferase (ALT) and sorbitol dehydrogenase (SDH) activity were measured spectrophotometrically (1, 18,23) using commercial diagnostic kits (Sigma Chemical Co.). Reduced GSH was measured in liver homogenates by enzymatic conjugation with l-chloro-2,4-dinitrobenzene (6,7). Results are expressed as international units of ALT activity per liter of plasma (IU/L), Sigma units of SDH activity per milliliter of plasma (Sigma unitdml), and micromoles of GSH per gram of liver tissue (pmol/g).
Liver Histology. When animals were killed for collection of blood samples, samples of the liver were obtained from the distal portion of the great left lateral lobe. The tissue was fixed in phosphatebuffered formalin for at least 48 hr, processed routinely and then embedded in paraffin, sectioned, and stained with hematoxylin and eosin for light microscopic examination. Deparaffinized sections were also stained with the periodic acid Schiff reagent to determine the depletion of glycogen. All slides were coded and assessed in a blind fashion by a hepatopathologist (PH).
The following criteria were applied in grading the severity of the hepatic injury:
Grade I: Mild injury. This was characterized by foci of necrosis of single hepatocytes. The foci of necrosis occurred predominantly in zone 3, the cells around the terminal hepatic venules (central veins), but oc- casional necrotic cells were sometimes also seen in zone 2. Focal ballooning degeneration of hepatocytes was also apparent in zone 3. Grade 11: Moderate injury. Characterized by small areas of confluent necrosis of liver cells within zone 3, with variable numbers of hepatocytes at the periphery of zone 3 showing ballooning degeneration. Grade 111: Severe injury. Confluent necrosis, of the coagulative type, involving all hepatocytes in zone 3; this pattern of injury was accompanied by prominent congestion and hemorrhage.
Sections of liver from each of the time points were arbitrarily rank-ordered based on the amount of necrosis observed in from the least to the most injured.
Statistical Analysis. Plasma enzyme and hepatic GSH results are expressed as mean standard error (SE). Data were evaluated by ANOVA using the Student-Newman-Keuls (SNK) test to compare individual group means. Data were log-transformed prior to analysis in cases where a preliminary F-test indicated that variances were significantly inhomogeneous. For all analyses, p -= 0.05 was the mini imal requirement defining a statistically significant difference (2 1). Figure 1 illustrates mean plasma ALT activities for the various treatment groups at the indicated times after dosing. Treatment with TCE alone caused no detectable increase in ALT at any time point. In contrast, following treatment with CCl,, alone or in combination with TCE, plasma ALT was significantly increased (p < 0.05) at every time point from 3 to 72 hr. No synergistic interaction was evident at 3,6, or 12 hr. By 24 hr, however, the ALT values for CCl, + TCE were significantly (p < 0.05) greater than those for CCl, alone. The same was true after 48 and 72 hr, although by 72 hr values for both groups were only slightly elevated above control levels. Of the time points evaluated, the greatest difference between CCl, and CCl, + TCE groups was apparent at 24 hr (approximately a 4-fold potentiation).
RESULTS
The 2-way ANOVA confirms these observations indicating significant effects for "Treatment," "Time Since Dosing," and the interaction ofthe two factors h 1 0 -* ' 1 . A) Liver from a rat treated with 10% Emulphor (vehicle control) and sacrificed at 6 hr showing normal histology; a portal tract is seen on the right and a terminal hepatic venule on the left. B) Liver from a rat treated with TCE only and sacrificed at 6 hr. The liver is histologically normal; portal tracts are seen at top right and bottom right, and a terminal hepatic venule is apparent at top center. C) Liver from a rat treated with CCl, alone and sacrificed at 6 hr. The areas of pallor around the terminal hepatic venules are due to depletion of glycogen from hepatocyte cytoplasm; ballooning degeneration (arrows) is seen at the periphery of the areas of glycogen depletion. D) Liver showing "mild injury" from a rat treated with both CCI, and TCE and sacrificed at 6 hr. The zone 3 hepatocytes are palely stained due to glycogen depletion, and there are several tiny collections of lymphocytes at sites of focal necrosis of single hepatocytes (arrows). (center right). Fragmenting, pyknotic nuclei are seen in the necrotic cells; there is little evidence of cell lysis or of an inflammatory response. C) Liver showing evidence of recovery presumably from "marked injury" from a rat treated with CCl, and sacrificed at 72 hr. The liver has almost returned to normal; only a mild infiltrate of mononuclear cellslymphocytes and macrophages-is seen in the region of previous injury. D) Liver showing "marked injury" from a rat treated with CCl, and TCE and sacrificed at 72 hr. The pathology is similar to that seen a t 48 hr in the CC1,-treated animals (Fig. 5A) . A mononuclear cell infiltrate is seen in the areas of confluent necrosis (arrows) that surround the terminal hepatic venules. Some lysis of necrotic cells and collapse of the framework has occurred since the previous sacrifices at 48 hr (see Fig. 5B ).
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(p < 0.0001 in each case). Rank order indicated by SNK analysis 0, < 0.05) for "Treatment" was Control TCE Alone < CCl, Alone < CCl, + TCE. Rank order for "Time Since Dosing" was 3 hr < 72 hr < 6 hr < 12 hr < 48 hr < 24 hr.
Mean plasma SDH activities (Fig. 2) are in good agreement with the results for plasma ALT. The only,.notable difference between the 2 enzymes is th'at no synergistic toxicity was evident after 48 hr in the activities of SDH data.
Analysis ofhepatic GSH content (Fig. 3) indicates a somewhat more complicated pattern of changes. Treatment with TCE alone increased mean GSH levels above those of control rats at all time points t show confluent necrosis with loss of cell detail and tiny, fragmenting pyknotic nuclei. Focal ballooning degeneration is seen at the periphery of the necrotic tissue. The dark color of the surviving hepatocytes is due to overstaining of the section. from 12 to 72 hr, although the actual increase was relatively small (mean increase of 18%). The combination of CCl, + TCE caused a depletion (47%) of GSH at 24 hr that was not observed following CCl, alone. At 48 hr after dosing, on the other hand, groups treated with CCl, alone and the CCl, + TCE combination had significantly elevated hepatic GSH concentrations (47-54%) compared to controls and remained elevated (3M4Yo) even after 72 hr, although they appeared to be returning to normal. These changes are superimposed on a background of time-dependent increases in hepatic GSH from 3 through 12 hr in all treatment groups. Figures 4A-F and 5A-D present typical examples of the observed hepatic injuries in the various experimental groups. Livers from rats treated with 10% Emulphor (Fig. 4A ) or with TCE alone (Fig.  4B) were histologically normal at 6 hr and at all other time points evaluated. This is consistent with past results, which have shown that neither of these treatments causes any histopathologic changes in F-344 rats evaluated 24 hr after dosing (22) .
By 3 hr after dosing, both CCl, and CCl, + TCE caused relatively minor injury in the form of a few scattered foci of necrosis in zone 3. There was no evidence of potentiation of the liver injury by TCE.
At 6 hr, all livers from animals treated with CCl, and CC1, + TCE showed mild focal necrosis and focal ballooning of hepatocytes in zone 3 (Grade I injury) ( Fig. 4C and D, respectively) . In both treatment groups, zone 3 hepatocytes had paler than normal cytoplasm due to the depletion of glycogen (confirmed by a periodic acid Schiff stain for glycogen). The 2 livers ranked as having the largest number of focal necroses were from the CCl, + TCE group while the 3 least injured livers were from the CCl, group. These observations suggest that slight potentiation may have been occumng by this time point.
All livers in both the CC1, and the CCl, + TCE groups showed mild focal necrosis (Grade I injury) by 12 hr. Foci of necrotic cells were seen in both zones 2 and 3 and a lymphocytic infiltrate was seen in the necrotic areas. Zone 3 hepatocytes again showed glycogen depletion. No obvious potentiation of the CC1,-induced injury by TCE was observed. The pathology was similar to that seen at 6 hr and has not been illustrated. By 24 hr, the livers in both the CCl, and the CCl, + TCE groups showed "moderate" injury in the form of numerous, small confluent areas of necrosis of hepatocytes in zone 3 with focally ballooned cells at the periphery of zone 3 (Grade I1 injury) ( Fig. 4E and F, respectively); the most severely injured liver showed marked injury (Fig. 4F9 . The livers with the most extensive areas of necrosis were from the CCl, + TCE group. These livers also showed prominent hemorrhage and congestion in the necrotic areas. Three of the 4 livers could be readily distinguished from the less injured livers of the CCl, group, indicating that by 24 hr liver injury was more severe in the TCE + CCl, group.
At 48 hr, the difference between the CCl, and CCl, + TCE groups was even more apparent ( Fig. 5A and By respectively). Livers from rats treated with CCl, alone showed a distinctive and uniform pattern of injury with regenerative features predominating over necrosis. Most of the necrotic hepatocytes and extravasated red blood cells had undergone lysis. Mild to moderate lymphocytic infiltrate and occasional enlarged macrophages were observed in the damaged tissue, and numerous mitotic figures were prominent in all zones. Livers of rats dosed simultaneously with both chemicals were characterized by coagulative necrosis of the whole of zone 3 (Grade 111). Only a few of the necrotic cells had undergone lysis, although many had lost their nuclei. Inflammatory infiltration was also less prominent than in the CCl, alone group, although mitotic figures were again present in all zones. Overall, these observations suggest a delayed recovery associated with the synergistic combination. As at 48 hr, 2 distinct patterns of injury were apparent in the livers at 72 hr after dosing. The livers from the CC1, group (Fig. 5C ) no longer showed any evidence of ballooning degeneration or necrosis; however, scattered mitoses were still apparent and variable numbers of lymphocytes and enlarged Kupffer cells were seen in the vicinity of the terminal hepatic venules. The features seen in the livers of the CCl, + TCE group (Fig. 5D ) closely resembled those of the resolving injury seen after 48 hr in the rats treated with CCl, alone. Most of the necrotic hepatocytes in zone 3 had undergone lysis, the reticulin framework was collapsed, and there was an associated lymphohistiocytic infiltrate. Numerous mitoses were apparent, indicating regenerative activity. Once again, potentiation and possibly delayed recovery due to the interaction was apparent.
DISCUSSION
In.these studies, it was demonstrated that simulianebus administrations of TCE and CCl, resulted in a quantitative increase in the severity of liver injury, as compared to that produced by either chemical alone. Thus, the combination of 2 chemicals resulted in an interactive toxicological event, as defined by the National Research Council (12). Since the dose of TCE that was used did not result in liver injury, we conclude that TCE potentiated the hepatotoxicity of CCl,. Other investigators have reached this same conclusion (14) . Although only 1 dose of each chemical was used in this study, pre-vious results have shown that the degree of the synergistic interaction between TCE and CCl, depends on the dose of each chemical (22) .
The results also demonstrate the importance of comparison of multiple end points and time points to assess the degree of the interactive effect between these 2 chemicals. When the activities of plasma enzymes were used to assess the degree of liver injury, TCE potentiation of CCl, hepatic injury was most evident at 24 hr after simultaneous administrations of both chemicals. By 48 hr, the extent of the interaction was much less obvious. In fact, at this time point, plasma SDH activities do not reveal any differences in liver injury produced by CCl, alone or the combination of TCE and CCl,. Histologic analysis, in contrast, revealed that the synergistic interaction produced by the 2 chemicals was most evident at 48 hr after dosing. As plasma enzyme activities declined substantially, the hepatic lesion was progressing. Cellular injury and regenerative activity were still observable 72 hr after dosing, when peripheral enzyme markers had returned to near normal levels.
As previously reported, the combination of CCl, and TCE caused more extensive liver injury than CCl, alone 24 hr after dosing. Even more striking was the apparent delay in recovery revealed by the histological analysis in the CCl, + TCE group after 48 and 72 hr. This delay is intriguing in light of recent investigations of another hepatotoxic combination, CCl, and chlordecone. It has been proposed that inhibition of hepatic repair mechanisms by chlordecone may account for that compound's enhancement of CCl, hepatotoxicity (1 0). Our finding that synergistic injury is not histologically distinctive until some time between 12 and 24 hr after dosing also implies that the events responsible for the TCE + CCl, synergism may arise not at the moment of exposure but at later time points. Other findings by us support this conclusion. We found that simultaneous administration of TCE with 14cc1, did not alter the I4Cc1, biotransformation of CCl, to I4CO2, an end product of CCl, metabolism. Similarly, TCE did not promote increases in CCl,-induced lipid peroxidation, as assessed by ethane exhalation during the first 6 hr after administration of TCE + CCl, (20) . Biotransformation and lipid peroxidation are early events involved in the initiation of CCI,-induced hepatocellular injury (17) . The fact that they were not altered by TCE suggests the events responsible for this synergistic interaction occur during the progression and/or resolution of injury.
One event that did correlate with the development of the synergistic interaction between TCE and CCl, was GSH depletion. Only in the rats treated with TCE + CCl, did hepatic GSH levels decline. 
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This loss of GSH was not an early event, as is often observed after exposure of rats to such halogenated hydrocarbons as bromobenzene or chloroform. In fact, hepatic GSH content increased between 3 and 12 hr after administration of TCE, CC14, or TCE + CCl,. Between 12 and 24 hr, the hepatic GSH concentration declined only in the rats administrated both chemicals. This finding may be important in that hepatic GSH concentrations usually increase within 24 hr after CCl, (8). Thus, this 12-24 hr window may provide an opportunity to determine whether the loss of GSH is mechanistically involved in the TCE potentiation ofCC1,-induced liver injury or is a passive response that merely reflects the severity of the liver injury and a decrease in viable tissue.
Increases in hepatic GSH were observed by 48 hr after dosing with CCl,, alone or in combination with TCE. The origin of these alterations may therefore be similar to that of the increases noted by Harrisch and Meyer (8) . It has also been reported by other investigators that depletion of hepatic GSH releases inhibition of enzymes controlling GSH synthesis (1 1). A surge in GSH synthesis thus leads to a rebound in GSH concentration following depletion. While no decrease was noted following treatment with CCl, alone, it is possible that some depletion occurred between 12 and 24 hr and that the normal concentration observed after 24 hr was already rebounding toward the elevated value measured after 48 hr. Also uncertain is why hepatic GSH increased in all treatment groups from 3 to 12 hr after dosing. Speculative explanations include circadian variation in baseline GSH and re-feeding of the animals following the pre-dose fasting period (1 9).
Histological examination of liver sections revealed a loss of hepatic glycogen in both the CCl, and the TCE + CCl, rats. At 6 and 12 hr, it was not possible to distinguish between the livers of the CCl, and TCE + CCl, group with respect to glycogen loss. Whether or not this loss of glycogen coupled with the associated loss of hepatic GSH in the TCE + CCl, group may predispose these hepatocytes to additional cellular injury is unknown.
Ine.gummary, the evaluation of both biological mail& (ALT, SDH, and GSH) and liver histology at a series of times following treatment with the synergistic, hepatotoxic combination of CCl, + TCE reveals a much richer and more detailed picture of the resulting injury than a single 24-hr "snapshot." This approach has also yielded clues regarding the nature of the interaction, which may prove valuable in designing future mechanistic studies.
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